Karyopharm Therapeutics
KPTI
#10247
Rank
S$6.41 M
Marketcap
$0.76
Share price
-4.10%
Change (1 day)
-59.71%
Change (1 year)

Karyopharm Therapeutics (KPTI) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : S$0.46 Billion

According to Karyopharm Therapeutics 's latest financial reports the company's total liabilities are S$0.46 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Karyopharm Therapeutics - Total liabilities on balance sheet (from 2012 to 2024)

Total liabilities by year

Year Total liabilities Change
2024-12-31S$0.47 B-4.24%
2023-12-31S$0.49 B-1.01%
2022-12-31S$0.50 B-3.45%
2021-12-31S$0.52 B49.87%
2020-12-31S$0.34 B5.06%
2019-12-31S$0.33 B53.12%
2018-12-31S$0.21 B217.54%
2017-12-31S$67.98 M158.92%
2016-12-31S$26.25 M8.69%
2015-12-31S$24.15 M35%
2014-12-31S$17.89 M329.04%
2013-12-31S$4.17 M-88.31%
2012-12-31S$35.69 M38.68%
2011-12-31S$25.73 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
S$94.41 B 20,084.63%๐Ÿ‡บ๐Ÿ‡ธ USA
S$101.73 B 21,648.68%๐Ÿ‡บ๐Ÿ‡ธ USA
S$44.73 B 9,463.26%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.93 B 100.75%๐Ÿ‡บ๐Ÿ‡ธ USA